Accumulating evidences suggested a challenging role of the cyclooxygenase-2 (COX-2) prostanoid pathway in inflammation and the physiopathology of liver diseases, such as cirrhosis and HCC [12]. This evidence concerns the gene PTGS2 and hepatocellular carcinoma.